Opaleye Management Inc. is an investment advisor that manages 225.1 MM dollars in regulatory AUM and has 3 employees, of which 3 perform investment advisory functions.

The manager's has disclosed holdings from 12/31/13 to 06/30/16. The fund's latest filing disclosed 140MM in positions, representing 62% of the manager's regulatory AUM.


Top 25%
2.75yr StockAlpha Register for more...

Fundamental & Technical Factor Exposure

Market Cap Beta Volatility
Momentum (12M) Momentum (6M) Momentum (3M)
Price/Book Price/Earnings Price/Cash Flow
Dividend Yield Sales Growth Earnings Growth
EBIDTA Margin Debt/Assets Hedge Fund Crowding

OPALEYE MANAGEMENT Since Last Filing Return Details

Ticker Size Sector Stock Move StockAlpha Attribution Days to Liquidate Trade Crowdedness
AXGN 10.44% Health 27.91% 3.12% 10 2%
MDGN 7.75% Health -12.07% -0.63% 13 1%
Get the Full Report
Logo of CNBC
Wall Street Journal Logo
Pensions & Investments logo
BloomBerg Logo

OPALEYE MANAGEMENT Founders and Key Employees

Name Title In Position Since
James A. Silverman President/Chief Compliance Officer February-1996

OPALEYE MANAGEMENT Brokers, Custodians, Auditors and Administrators

Type Company
Administrator Pro
Auditor Pro
Custodian Pro
Custodian Pro
Prime Broker Pro

OPALEYE MANAGEMENT Investment Strategy

Methods of Analysis, Investment Strategies and Risk of Loss

We employ a research process that involves analyzing company fundamentals. Such as asset valuations, quality of management, likely catalysis and/ or innovative products and the competition.

Opaleye's strategy for managing the Fund is to actively invest, both long and short, in equity securities of biotechnology, specialty pharmaceutical and med-device companies. In pursuing this strategy, the Fund will focus its long investments in equity securities of companies that may not be profitable yet but whose share price may grow significantly in the near term or over a 1-2 year or longer period based on their therapeutic development and financial objectives. The Fund will also seek to actively invest in stock and derivative transactions to profit from “binary” events, such as clinical data milestones or a U.S. Food and Drug Administration (“FDA...
Get the Full Report

OPALEYE MANAGEMENT Portfolio Concentration


OPALEYE MANAGEMENT Contact Information

Phone Number: 617-229-5085
Fax Number: 617-812-0515



The information contained herein: (1) is proprietary to Symmetric and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Symmetric nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance and skill metrics are no guarantee of future results. "Symmetric," "Symmetric.io" and the Symmetric logo are marks of Symmetric, Inc. Read our privacy policy here. Read our terms of use here
Path B